OR WAIT null SECS
Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.
January 28, 2010
The Director-General of the European Generic medicines Association has reiterated the group's Vision 2015 plan.
Two US senators have introduced the Nanotechnology Safety Act of 2010, which would establish a program within the US Food and Drug Administration to assess the health and safety implications of nanotechnology in everyday products.
The European Medicines Agency has launched a public consultation on its Road Map to 2015, a strategic vision that lays out the agency's priorities for the next five years.
January 22, 2010
The EU?s Commissioner-designate for Health and Consumer Policy, John Dalli, has said that he is looking forward to the challenge of integrating the pharmaceutical area into public health as part of his role.
Targeted nanoparticles that can cling to artery walls and slowly release medicine could offer an alternative to drug-releasing stents in some patients with clogged or damaged arteries, according to researchers at the Massachusetts Institute of Technology (MIT) and the Harvard Medical School.
January 21, 2010
The EU's Commissioner-designate for Health and Consumer Policy, John Dalli, said that he is looking forward to the challenge of integrating the pharmaceutical area into public health as part of his role.